Notification of Implementation – Medicinal Products
Notification of Implementation – Medicinal Products
Documents from [1994] to [1996]
Identity Statement
Paper
Carr, Mary
Content and Structure
Medicinal products - amending Protocol 47 and certain annexes to the EEA Agreement
Notification of national measures in Norway implementing: Council Directive 92/27/EEC on the labelling of medical products for human use and on package leaflets
Notification of national measures implementing Council Directive 94/62/EC on packaging and packaging waste
Letter of formal notice regarding Council Directive 89/343/EEC (radiopharmaceuticals) and reasoned opinion regarding Council Directive 89/105/EEC (Transparency Directive)
Notification of national measures in Norway on the advertising of medicinal products for human consumption, Council Directive 92/28/EEC
Notification of national measures concerning substances which may be used in the illicit manufacture of narcotic drugs and psychotropic substances from the Norwegian Ministry of Health and Social Affairs
Information on the implementation of acts under the responsibility of the Ministry of Health and Social Affairs
Reasoned opinion of Norwegian Department of Health - substances used in the illicit manufacture of narcotic drugs, Directives 92/109/EEC and 93/46/EEC (Drug precursors)
Notification of national measures implementing directive 91/412/EEC of 23 July 1991 laying down the principles and guidelines of good manufacturing practice for Veterinary Medicinal Products
Conditions of Access and Use
English, Norwegian
Textual
Allied Materials
Notes
New case numbers: 18710 - 18716